Your browser doesn't support javascript.
loading
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
Moon, Ji-Yong; Kim, Sang Hyuk; Kim, Youlim; Lee, Hyun; Rhee, Chin Kook; Ra, Seung Won; Lee, Chang Youl; Park, Joo Hun; Park, Yong Bum; Yoo, Kwang Ha.
Afiliación
  • Moon JY; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
  • Kim SH; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, South Korea.
  • Kim Y; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
  • Lee H; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
  • Rhee CK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Ra SW; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Lee CY; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, South Korea.
  • Park JH; Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, South Korea.
  • Park YB; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, South Korea. Electronic address: bfspark2@gmail.com.
  • Yoo KH; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea. Electronic address: 20010025@kuh.ac.kr.
Pulm Pharmacol Ther ; 85: 102298, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38604404
ABSTRACT

BACKGROUND:

A suboptimal peak inspiratory flow rate (PIFR) in dry-powder inhaler (DPI) users can lead to insufficient therapeutic effects in the treatment of chronic obstructive pulmonary disease (COPD). However, few data on the prevalence of and factors associated with suboptimal PIFR in Korean patients with COPD are available.

METHODS:

We conducted a cross-sectional study of patients with COPD who had been using DPIs for more than three months. PIFR was measured using an In-Check DIAL G16 device. Suboptimal PIFR was defined as below the resistance-matched threshold. Multivariable logistic regression analysis was used to determine factors associated with suboptimal PIFR.

RESULTS:

Of 444 DPI users with COPD, the rate of suboptimal PIFR was 22.0 % (98/444). In a multivariable analysis, significant factors associated with suboptimal PIFR were age (adjusted odds ratio [aOR] = 1.06 by 1-year increase; 95 % confidence interval [CI] = 1.02-1.09), male sex (aOR = 0.28; 95 % CI = 0.11-0.73), body mass index (BMI) (aOR = 0.91 by 1 kg/m2 increase; 95 % CI = 0.85-0.99), post-bronchodilator forced vital capacity (FVC) %pred (aOR = 0.97 by 1%pred increase; 95 % CI = 0.95-0.99), and In-Check DIAL R2-type inhaler [medium-low resistance] use (aOR = 3.70 compared with R1-type inhalers [low resistance]; 95 % CI = 2.03-7.03).

CONCLUSIONS:

In Korea, more than one-fifth of DPI users with COPD had a suboptimal PIFR. The factors associated with suboptimal PIFR were age, female gender, low BMI, low FVC, and R2-type inhaler use. Therefore, clinicians should carefully evaluate the possibility of suboptimal PIFR when prescribing DPIs.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Inhaladores de Polvo Seco Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Inhaladores de Polvo Seco Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Corea del Sur